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Abstract
BACKGROUND
Hospital admissions are common among patients with cirrhosis, but patient
factors associated with hospitalization have not been well characterized. Given
recent data suggesting increased liver transplant waitlist dropout among women,
we hypothesized that women on the liver transplant waitlist would have
increased rates of hospitalization compared with men.
AIM
To evaluate the role of gender on risk of hospitalization for patients on the liver
transplant waitlist, in order to help explain gender disparities in waitlist
outcomes.
METHODS
Patients listed for liver transplant at a single center in the United States were
prospectively enrolled in the Functional Assessment in Liver Transplantation
Study. Patients included in this retrospective analysis included those enrolled
between March 2012 and December 2014 with at least 12 mo of follow up and
without hepatocellular carcinoma. The primary and secondary outcomes were
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hospitalization and total inpatient days within 12 mo, respectively. Logistic and
negative binomial regression associated baseline factors with outcomes.
RESULTS
Of the 392 patients, 41% were female, with median (interquartile range) age 58
years (52-63) and model for end- stage liver disease 18 (15-22). Within 12 mo, 186
(47%) patients were hospitalized ≥ 1 time; 48% were readmitted, with a median of
8 (4-15) inpatient days. More women than men were hospitalized (54% vs 43%; P
= 0.03). In univariable analysis, female sex was associated with an increased risk
of hospitalization [odds ratios (OR) 1.6, 95% confidence interval (CI) 1.0-2.4; P =
0.03], which remained significant on adjusted multivariable analysis (OR 1.6,
95%CI: 1.1-2.6; P = 0.03). Female gender was also associated with an increased
number of inpatient days within 12 mo in both univariable and multivariable
regression.
CONCLUSION
Women with cirrhosis on the liver transplant waitlist have more hospitalizations
and inpatient days in one year compared with men, suggesting that the
experience of cirrhosis differs between men and women, despite similar baseline
illness severity. Future studies should explore gender-specific vulnerabilities to
help explain waitlist disparities.
Key words: Gender; Cirrhosis; Liver transplantation waitlist; Hospitalization;
Readmission; Women
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: In this single-center study of patients on the liver transplant waitlist, women
were significantly more likely to be hospitalized than men, and were hospitalized for a
more days within one year. Among those who were hospitalized at least once, there was
a trend toward higher rates of readmission among women compared to men. These
gender differences were independent of underlying severity of illness, as measured by
model for end- stage liver disease score, suggesting that perhaps traditional indicators of
liver disease severity do not adequately capture all contributors to illness, such as non-
hepatic comorbidities or socioeconomic factors, which may require acute inpatient care.
Citation: Rubin JB, Sinclair M, Rahimi RS, Tapper EB, Lai JC. Women on the liver
transplantation waitlist are at increased risk of hospitalization compared to men. World J
Gastroenterol 2019; 25(8): 980-988
URL: https://www.wjgnet.com/1007-9327/full/v25/i8/980.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i8.980
INTRODUCTION
Women have been shown to have worse transplant-related outcomes than men[1].
Rates of liver transplant are lower for women on the waitlist[2-6], and women are more
likely to die or become too sick for transplant than men[2,7,8].  In particular,  recent
studies suggest that women are underserved by the model for end- stage liver disease
(MELDNa) score[2], and that female sex is independently associated with a 10% higher
risk of delisting[8]. The reasons for these disparities are not completely understood.
One hypothesis  for  the gender disparity  in  outcomes for  patients  on the liver
transplant  waitlist  has  been that  women with  cirrhosis  have  a  different  disease
trajectory  than men with  cirrhosis,  either  because  they  are  sicker  at  baseline  or
experience  more  rapid  progression  of  cirrhosis  (i.e.,  from  compensated  to
decompensated cirrhosis)[4,9]. In several studies, women appear to have similar or even
lower MELDNa scores at listing compared with men and have fewer comorbidities,
suggesting that they are not sicker at baseline[3,4,8]. However, whether their disease
progresses more rapidly has not been previously explored. Hospital admissions may
be  a  surrogate  marker  for  disease  progression  that  more  accurately  captures
differences  in  the  experience  of  living  with  cirrhosis  for  women  and  men.  We
therefore  aimed to  evaluate  the  role  of  gender  on the  risk  of  hospitalization for
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patients with cirrhosis on the liver transplant waitlist.
MATERIALS AND METHODS
Patients
Our cohort included adult (≥ 18 years) patients seen as outpatients at the University of
California - San Francisco (UCSF) Liver Transplant Clinic, who were listed for liver
transplantation  at  UCSF from March  2012  to  December  2014,  and subsequently
enrolled  prospectively  in  the  Functional  Assessment  in  Liver  Transplantation
(FrAILT) Study[10,11].  Ninety-seven percent of invited participants enrolled in this
study[11,12]. Patients with time to complete a Numbers Connection Test (NCT) of > 120 s
were excluded because of concerns about their ability to provide informed consent[13].
For the purposes of this study, patients listed for transplant with MELD exception
points for hepatocellular carcinoma were excluded, as their reasons for hospitalization
(e.g., complications of locoregional therapy) may differ compared to patients solely
listed for decompensated cirrhosis.  Patients lost-to-follow up at 12 mo were also
excluded.
Baseline variables
At the time of study enrollment, patient demographics including age, gender, race,
etiology of cirrhosis, as well as medical comorbidities (e.g., diabetes and hypertension)
and baseline laboratory values were collected from the patient’s electronic health
record. All patients underwent frailty assessment using the Liver Frailty Index (LFI),
which is composed of hand grip, chair stands, and balance. “Frail” was defined as LFI
≥ 4.5[10].  Clinical information regarding the presence of ascites, ascertained by the
patient’s primary hepatologist, was recorded as absent, mild/moderate, or severe,
then  further  classified  as  absent  or  present  for  the  current  study.  Hepatic
encephalopathy was classified as none/mild versus moderate/severe based on the
patient’s performance on the NCT Score of < or > 45 s, respectively[13].
Outcomes
The primary outcome was any hospitalization within 12 mo from study enrollment.
The secondary outcome was the number of inpatient days within 12 mo. Information
on number of hospitalizations and inpatient days were obtained from manual review
of medical records at UCSF and review of external medical records in the case of
hospital admissions elsewhere[14]. As part of their listing agreement for liver transplant
at  our  center,  all  patients  were  required  to  report  hospitalizations  to  outside
institutions at time of admission. Patients who died or were transplanted within 12
mo were censored at the time of their waitlist event (n = 82). A 12-mo study period
was selected to minimize confounding from women remaining on the waitlist longer
than men due to lower rates of transplant.
Statistical analysis
Categorical data were presented as percentages; groups were compared using chi-
square  tests.  Continuous variables  were presented as  medians and interquartile
ranges (IQR); groups were compared using Wilcoxon Rank-Sum tests. Univariable
logistic  regression  with  odds  ratios  (OR)  evaluated  the  association  of  all  listed
covariates with the primary outcome of hospitalization within 12 mo. Univariable
negative binomial regression with incidence rate ratios (IRR) evaluated the association
of all listed covariates with the secondary outcome of number of hospitalized days
within  12  mo.  Variables  significant  at  a  P-value  <  0.2  were  included  in  the
multivariable  models.  Backward elimination (P  >  0.05  for  removal)  was used to
develop the final multivariable models. Two-sided P-values < 0.05 were considered
statistically  significant.  All  analyses  were  performed using  Stata  15.1  statistical
software (College Station, TA, United States). The statistical methods of this study
were reviewed by multiple individuals with biomedical statistical training. This study
was approved by the institutional review board at the UCSF.
RESULTS
Baseline characteristics
A  total  of  392  patients  were  enrolled  between  March  2012  and  December  2014.
Women comprised 41% of the cohort, 61% were non-Hispanic Caucasian, and median
(IQR) age was 58 years (51-63). The etiology of cirrhosis was chronic hepatitis C in
43% of the cohort; median (IQR) MELDNa was 18 (15-22) and median (IQR) albumin
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was 3.0 mg/dL (2.6-3.4).  Thirty-four percent of patients had ascites and 42% had
moderate or severe hepatic encephalopathy. Sixteen percent of the patients were
characterized  as  frail.  Baseline  demographics,  comorbidities  and  cirrhosis
complications by gender are shown in Table 1. Men were more likely than women to
have cirrhosis due to Hepatitis C (48% vs 35%, P < 0.01) and alcohol (23% vs 14%, P =
0.02) and more likely to have coronary artery disease (6% vs 2%, P = 0.05); women
were more likely to have cirrhosis due to autoimmune liver disease (24% vs 9%, P <
0.01).
Hospitalizations
During the 12-mo study period, 186 (47%) patients were hospitalized at least once. Of
these  186  patients,  89  (48%)  were  readmitted  at  least  once  and  47  (25%)  were
readmitted more than once. Among patients hospitalized at least once, median (IQR)
number  of  hospitalizations  within  12  mo  was  1  (1-3),  median  (IQR)  number  of
inpatient days was 8 (4-15), and median (IQR) length of stay was 5 d (3-8).
In univariable analysis,  the factors associated with at least one hospitalization
within 12 mo were female gender [OR 1.6, 95% confidence interval (CI) 1.0-2.4; P =
0.03], MELDNa (OR 1.1; 95%CI 1.1-1.2; P < 0.01), albumin (OR 0.4; 95%CI: 0.3-0.6; P <
0.01), ascites (OR 2.3; 95%CI: 1.5-3.5; P < 0.01), and frailty (OR 3.6; 95%CI: 2.0-6.5; P <
0.01).
Gender and hospitalization
More women than men were hospitalized at least once within the 12-mo study period
(54% vs 43%, P = 0.03). As noted above, in univariable logistic regression, the odds of
being hospitalized at least once within 12 mo were 1.6 times higher among women
compared to  men (P  =  0.03).  In  multivariable  analysis,  female  gender  remained
significantly associated with hospitalization after adjusting for MELDNa, albumin,
ascites, and frailty (adjusted OR 1.6, 95%CI: 1.1-2.6; P = 0.03) (Table 2).
Women also had a higher median (IQR) number of total inpatient days within 12
mo compared with men [2.5 (0-10) vs  0 (0-6.5), P  = 0.02]. On univariable negative
binomial regression, female gender was associated with a higher number of total
inpatient  days  within  12  mo (IRR 1.7,  95%CI  1.1-2.6,  P  =  0.02).  This  association
persisted in multivariable analysis after adjusting for MELDNa and albumin (adjusted
IRR 1.9, 95%CI: 1.2-3.0, P < 0.01) (Table 3). Among the 186 patients hospitalized at
least once, there was a trend toward women being readmitted more often than men
(54% vs 42%), but this did not reach statistical significance (P = 0.11).
DISCUSSION
Hospital  admissions  are  common  among  patients  with  cirrhosis  due  to  portal
hypertensive complications[15].  Hospitalizations in patients with cirrhosis are also
associated with high mortality, and account for a large proportion of the cost of end-
stage liver disease. In 2012, liver disease accounted for nearly 250000 hospitalizations
at an estimated cost of $3-12 billion each year[15-17], and rates of hospitalization as well
as  costs  have  been  increasing  over  time[15].  A  2014  study  also  showed that  pre-
transplant spending increased exponentially with severity of illness for patients on the
liver transplant waitlist, likely due in large part to increased number and complexity
of hospitalizations[16]. In light of the increased mortality and high costs associated with
hospitalizations in patients with cirrhosis, we wondered whether differential rates of
hospitalization could help explain the gender disparity on the liver transplant waitlist.
Consistent with previous studies on hospitalizations in patients with cirrhosis, we
observed that hospitalizations were quite common: Nearly half of patients on the liver
transplant waitlist in our study were hospitalized at least once within one year, and
approximately one half  of  those were readmitted at  least  once.  But our analyses
investigating  gender  differences  in  hospitalizations  expand  upon  prior  work.
Specifically, in the current study, we found that in one year, women on the liver
transplant waitlist were significantly more likely to be hospitalized than men. They
also were hospitalized for a higher number of days within one year. Among those
who  were  hospitalized  at  least  once,  there  was  a  trend  toward  higher  rates  of
readmission among women in comparison to men.
What might explain this gender disparity in hospitalizations? Here, we explore
several possible explanations. While the most obvious hypothesis would be that the
women in our cohort were sicker than the men, we found that traditional markers of
illness severity for cirrhosis, including MELD and hepatic decompensation (presence
of ascites or hepatic encephalopathy), did not differ at baseline by gender, confirming
findings from prior studies[3,4,8].  Perhaps, then, these traditional indicators of liver
disease severity do not adequately capture all contributors to illness, such as non-
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Table 1  Baseline characteristics by gender1
Characteristics Total (n = 392) Men (n = 231, 59%) Women (n = 161, 41%) P value
Age, yr 58 (51-63) 57 (50-63) 58 (52-63) 0.51
Race 0.64
Non-Hispanic Caucasian 240 (61) 142 (62) 98 (61)
Black 9 (2) 4 (2) 5 (3)
Hispanic 105 (27) 59 (26) 46 (29)
Asian 16 (4) 11 (5) 5 (3)
Other 22 (6) 15 (7) 7 (4)
Etiology < 0.01
HCV 168 (43) 112 (49) 56 (35)
Alcohol 75 (19) 53 (23) 22 (14)
NAFLD/NASH 55 (14) 24 (10) 31 (19)
Autoimmune2 59 (15) 21 (9) 38 (24)
HBV 3 (1) 3 (1) 0 (0)
Other 32 (8) 18 (8) 14 (9)
BMI, kg/m2 28.5 (25.0-33.7) 28.8 (25.3-34.1) 28.0 (24.2-33.0) 0.13
Diabetes mellitus 115 (29) 71 (31) 44 (27) 0.47
Coronary artery disease 17 (4) 14 (3) 3 (2) 0.05
Hypertension 153 (39) 98 (42) 55 (34) 0.10
Stroke 7 (2) 4 (2) 3(2) 0.92
Dialysis 16 (4) 7 (3) 9 (5) 0.21
MELDNa 18 (15-22) 18 (15-22) 19 (15-23) 0.13
Albumin, g/dL 3.0 (2.6-3.4) 3.0 (2.6-3.4) 3.1 (2.7-3.4) 0.30
Presence of ascites 133 (34) 77 (33) 56 (35) 0.77
Numbers connection test, s 41 (30-58) 42 (32-58) 40 (29-58) 0.30
Moderate/severe HE 165 (42) 98 (42) 67 (42) 0.87
Frail 62 (16) 26 (16) 26 (17) 0.88
1Data presented as n (%) or median (IQR).
2Combined autoimmune hepatitis, primary sclerosing cholangitis, and primary biliary cholangitis.
IQR: Interquartile range; HCV: Hepatitis C; NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis; HBV: Hepatitis B; BMI: Body
mass index; MELDNa: Model for end-stage liver disease with serum sodium; HE: Hepatic encephalopathy.
hepatic  comorbidities  or  socioeconomic  factors,  that  may  affect  an  individual’s
vulnerability to adverse events that necessitate acute inpatient care. Our study also
raises the possibility of systematic differences in the management of women and men
with cirrhosis - either there exists a lower threshold for admission in women or a gap
in coordination of care from the inpatient setting to outpatient recovery. Interestingly,
among those who were hospitalized at least once, women were re-admitted almost
30% more frequently than men, though this did not reach statistical significance. It is
also possible that differences in etiology of cirrhosis may contribute to differences in
disease progression that lead to this gender disparity. Men were more likely to have
cirrhosis due to Hepatitis C and alcohol, which are often no longer active by the time
of  listing  for  liver  transplant.  Women,  in  contrast,  are  more  likely  to  have
autoimmune hepatitis, which often continues to cause liver injury until the time of
transplant.
Furthermore, it is possible that women are hospitalized for different reasons than
men. Specifically, women may be more susceptible to complications of sarcopenia,
such as infection or hepatic encephalopathy, which may lead to increased risk of
hospitalization. Although proportion of “frail” patients did not differ between men
and women in our cohort,  more subtle  differences in muscle mass could lead to
differences  in  cirrhosis  complications.  Unfortunately,  given  the  complexity  of
ascertaining cause of hospitalization (as many patients with cirrhosis have multiple -
such as acute kidney injury, hepatic encephalopathy, worsening ascites), we were not
able to accurately capture indications for hospitalization, which is a limitation of this
study. Other factors that could contribute to hospitalization were also not captured in
this  study,  such as  medication complexity  and adherence,  diuretic  resistance  in
patients  with  ascites,  and  social  support.  Future  studies  should  evaluate  such
predictors, though some, such as social support or adherence, may be difficult to
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Table 2  Logistic regression for hospitalization within 12 mo
Characteristics
Univariable Multivariable
OR 95%CI P value aOR 95%CI P value
Female gender 1.57 1.05-2.35 0.03 1.64 1.05-2.56 0.03
Non-Hispanic Caucasian 0.81 0.54-1.22 0.31
Age per year 1.00 0.98-1.02 0.95
Hypertension 1.26 0.84-1.89 0.26
Diabetes mellitus 1.31 0.85-2.02 0.23
Coronary artery disease 0.98 0.37-2.60 0.97
Stroke 0.83 0.18-3.75 0.81
Dialysis 1.89 0.67-5.31 0.22
BMI per 1 kg/m2 1.02 0.99-1.05 0.24
Autoimmune1 0.61 0.35-1.08 0.09
MELDNa per 1 point> 1.13 1.07-1.18 < 0.001 1.08 1.03-1.13 0.001
Albumin per 1 mg/dL 0.44 0.31-0.63 < 0.001 0.53 0.36-0.78 0.001
Ascites 2.28 1.49-3.50 < 0.001 1.61 1.00-2.57 0.05
> NCT per 1 s 1.01 1.01-1.02 0.006
Moderate/severe HE 1.17 0.78-1.75 0.45
Frail 3.59 1.97-6.55 < 0.001 2.37 1.24-4.54 0.009
1Combined autoimmune hepatitis, primary sclerosing cholangitis, and primary biliary cholangitis. OR: Odds
ratio; CI: Confidence interval; aOR: Adjusted odds ratio; BMI: Body mass index; MELDNa: Model for end-
stage liver disease with serum sodium; NCT: Numbers connection test; HE: Hepatic encephalopathy.
collect on a large scale. Another limitation is that this is a US-based single center study
serving a large catchment area within an open hospital network, so it is possible that
we did not capture all hospitalizations for every patient. However, all of the patients
enrolled in this  study were waitlisted at  our center  and were required to report
outside  hospitalizations.  Therefore,  we  believe  that  our  ascertainment  of
hospitalizations was reliable, but validation of our gender-based findings in a larger,
closed health system is warranted. It is also possible that rates of and reasons for
hospitalization for patients on the liver transplant waitlist differ in countries with
different healthcare systems,  so our findings should be replicated outside of  the
United States as well.
Despite these limitations, this study describes significant gender differences in
hospitalizations for patients on the liver transplant waitlist and thus, takes us one step
closer to understanding the gender disparity in liver transplant waitlist mortality and
dropout. Our finding that women are more likely to be hospitalized than men suggest
that the experience of cirrhosis differs between women and men despite similarities in
traditional  measures of  severity of  illness.  As the hepatology community moves
toward developing cirrhosis-specific models of care, our data strongly suggest that
these models may need to consider gender-specific vulnerabilities. Future studies are
needed to  evaluate  gender-specific  interventions  in  order  to  truly  optimize  the
management of women and men living with cirrhosis.
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Table 3  Binomial regression for number of hospitalized days within 12 mo
Characteristics
Univariable Multivariable
IRR 95%CI P value aIRR 95%CI P value
Female gender 1.68 1.08-2.60 0.02 1.92 1.23-2.99 0.004
Non-Hispanic Caucasian 0.86 0.55-1.35 0.52
Age per year 1.00 0.98-1.03 0.80
Hypertension 1.31 0.84-2.04 0.24
Diabetes mellitus 1.05 0.65-1.69 0.85
Coronary artery disease 0.52 0.18-1.55 0.28
Stroke 0.20 0.03 0 1.16 0.13
Dialysis 1.63 0.55-4.87 0.34
BMI per 1 kg/m2 1.01 0.98-1.05 0.42
Autoimmune1 0.59 0.32-1.09 0.11
MELDNa per 1 point 1.09 1.04-1.14 < 0.001 1.08 1.03-1.13 0.001
Albumin per 1 mg/dL 0.58 0.39-0.84 0.005 0.47 0.31-0.70 < 0.001
Ascites 1.72 1.09-2.70 0.02
NCT per 1 s 1.00 1.00-1.01 0.13
Moderate/severe HE 1.28 0.82-1.98 0.28
Frail 2.12 1.17-3.81 0.007
1Combined autoimmune hepatitis, primary sclerosing cholangitis, and primary biliary cholangitis. IRR: Incidence rate ratio; CI: Confidence interval; aIRR:
Adjusted incidence rate ratio; BMI: Body mass index; MELDNa: Model for end-stage liver disease with serum sodium; NCT: Numbers connection test; HE:
Hepatic encephalopathy.
ARTICLE HIGHLIGHTS
Research background
It is well-established in the literature that women have worse transplant-related outcomes than
men, including lower rates of transplant and increased risk of waitlist mortality and dropout.
The reasons for these disparities are unclear.
Research motivation
Hospital admissions are common among patients with cirrhosis, and may be a surrogate marker
for disease progression that more accurately captures the differences in experience between men
and women living with cirrhosis, and may help explain gender disparities in waitlist outcomes.
Research objectives
Thus, we aimed to evaluate the role of gender on risk of hospitalization for patients on the liver
transplant waitlist.
Research methods
Our cohort included adults (≥ 18 years) with cirrhosis listed for liver transplant at University of
California  -  San  Francisco  (UCSF)  from  March  2012  to  December  2014  who  were  seen  as
outpatients and enrolled as a part of a prospective trial. Patients listed for transplant with model
for  end-  stage  liver  disease  (MELD)  exception  points  for  hepatocellular  carcinoma  were
excluded,  as  were  patients  lost-to-follow  up  at  12  mo  and  those  with  severe  hepatic
encephalopathy. At the time of study enrollment, patient demographics and baseline laboratory
values were collected. Clinical information regarding complications of patients’ liver disease
were assessed by enrolling clinician. The primary outcome was any hospitalization within 12 mo
from study enrollment, and the secondary outcome was the number of inpatient days within 12
mo. Logistic regression and negative binomial regression evaluated the association of all listed
covariates with the primary and secondary outcomes.
Research results
A total of 392 patients were enrolled during the study period; 41% were women and 61% were
non-Hispanic Caucasian, with median (interquartile ranges) age of 58 years (51-63). During the
12-mo study period, 186 (47%) patients were hospitalized at least once. Of these 186 patients, 89
(48%) were readmitted at least once and 47 (25%) were readmitted more than once. More women
than men were hospitalized at least once within the 12-mo study period (54% vs 43%, P = 0.03).
In univariable logistic regression, the odds of being hospitalized at least once within 12 mo was
1.6 times higher among women compared to men (P = 0.03). In multivariable analysis, female
gender remained significantly associated with hospitalization after adjusting for MELDNa,
albumin, ascites, and frailty [adjusted odds ratios (OR) 1.6, 95% confidence interval (CI) 1.1-2.6; P
WJG https://www.wjgnet.com February 28, 2019 Volume 25 Issue 8
Rubin JB et al. Gender and hospitalization on LT waitlist
986
= 0.03]. Female gender was also associated with a higher number of total inpatient days within
12 mo on univariable [incidence rate ratio (IRR) 1.7, 95%CI: 1.1-2.6, P = 0.02) and multivariable
analysis (adjusted IRR 1.9, 95%CI: 1.2-3.0, P < 0.01). There was a trend toward women being
readmitted more often than men (54% vs 42%), but this did not reach statistical significance (P =
0.11).
Research conclusions
Women on the liver transplant waitlist are significantly more likely to be hospitalized than men,
and are hospitalized for a higher number of days, even after adjustment for illness severity.
Among those who were hospitalized at least once, there was a trend toward higher rates of
readmission among women in comparison to men. These findings suggest that the clinical
course of cirrhosis among women and men differs despite similarities in traditional measures of
severity of illness.
Research perspectives
Our findings may help explain the gender disparities in liver transplant waitlist mortality and
dropout, by highlighting differences in the experience of living with cirrhosis for women and
men. Future studies are needed to evaluate gender-specific  interventions in order to truly
optimize the management of women and men living with cirrhosis and to eliminate waitlist
disparities.
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